Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02428855
Title Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST